P Hilgard, H Burkert. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Cyclophosphamide/analogs & derivativesHumansIfosfamide/adverse effectsInfusions, ParenteralKidney Diseases/chemically inducedKidney Diseases/prevention & controlMercaptoethanol/analogs & derivativesMesna/administration & dosage
Substances: See more » MercaptoethanolCyclophosphamideMesnaIfosfamide
Year: 1984 PMID: 6437825 DOI: 10.1016/0277-5379(84)90067-1
Source DB: PubMed Journal: Eur J Cancer Clin Oncol ISSN: 0277-5379